Reuters -- A U.S. advisory panel on Thursday narrowly backed Photocure ASA’s proposed imaging drug to help detect bladder cancer. A Food and Drug Administration advisory committee voted 9-8 that the benefits of the Hexvix product outweighed risks.
Reuters -- A U.S. advisory panel on Thursday narrowly backed Photocure ASA’s proposed imaging drug to help detect bladder cancer. A Food and Drug Administration advisory committee voted 9-8 that the benefits of the Hexvix product outweighed risks.
